5.17

2.08% -0.11

Orchestra Biomed Holdings Inc (OBIO)

Overview News Price History Discussions Forecast

Orchestra Biomed Holdings Inc stock is traded at $5.17, with a volume of 111.66K. It is down -2.08% in the last 24 hours and up +5.08% over the past month. Orchestra BioMed Holdings Inc is a biomedical innovation company accelerating high-impact technologies to patients through risk-reward sharing partnerships. Its partnership-enabled business model focuses on forging strategic collaborations with medical device companies to drive the global commercialization of the products it develops. The company's flagship product candidates include BackBeat Cardiac Neuromodulation Therapy (CNT) for the treatment of hypertension and Virtue Sirolimus AngioInfusionBalloon (SAB) for the treatment of atherosclerotic artery disease.

Previous Close:

$5.28

Open:

$5.35

24h Volume:

111.66K

Relative Volume:

1.21

Market Cap:

$195.55M

Revenue:

$2.76M

Net Income/Loss:

$-49.12M

P/E Ratio:

-3.4467

EPS:

-1.5

Net Cash Flow:

$-46.21M

1W Performance:

-1.90%

1M Performance:

+5.08%

6M Performance:

-35.62%

1Y Performance:

-40.71%

1-Day Range:

$5.01

$5.52

1-Week Range:

$5.01

$5.6966

52-Week Range:

$3.96

$10.06

Orchestra Biomed Holdings Inc Stock (OBIO) Company Profile

Name

Orchestra Biomed Holdings Inc

Sector

Healthcare (1176)

Industry

Biotechnology (685)

Phone

646-343-9298

Address

150 UNION SQUARE DRIVE, NEW HOPE

Employee

Twitter

Next Earnings Date

Latest SEC Filings

OBIO's Discussions on Twitter

Compare OBIO with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
OBIO Orchestra Biomed Holdings Inc	5.17	195.55M	2.76M	-49.12M	-46.21M	-1.50
VRTX Vertex Pharmaceuticals Inc	427.89	110.19B	10.63B	-479.80M	-1.35B	-1.99
REGN Regeneron Pharmaceuticals Inc	687.80	75.58B	13.85B	4.65B	3.32B	40.41
ARGX Argen X Se Adr	647.39	38.71B	1.86B	-40.29M	-1.28B	-0.85
ALNY Alnylam Pharmaceuticals Inc	264.99	34.18B	2.09B	-332.26M	16.06M	-2.62
BNTX Biontech Se Adr	117.25	28.11B	3.30B	-501.07M	1.03B	-2.1146

Orchestra Biomed Holdings Inc Stock (OBIO) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Jan-02-25	Initiated	Barclays	Overweight
Aug-22-24	Initiated	H.C. Wainwright	Buy
Jul-25-24	Initiated	B. Riley Securities	Buy
Jan-19-24	Initiated	Jefferies	Buy
Feb-24-23	Initiated	Piper Sandler	Overweight
Feb-07-23	Initiated	Chardan Capital Markets	Buy

View All

Orchestra Biomed Holdings Inc Stock (OBIO) Latest News

Jan 15, 2025

Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO) Shares Sold by Jane Street Group LLC - Defense World

Jan 15, 2025

Jan 08, 2025

Geode Capital Management LLC Purchases 11,002 Shares of Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO) - Defense World

Jan 08, 2025

Barclays PLC Increases Stake in Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO) - Defense World

Jan 08, 2025

Jan 03, 2025

Orchestra BioMed (NASDAQ:OBIO) Coverage Initiated by Analysts at Barclays - Defense World

Jan 03, 2025

Barclays Initiates Coverage of Orchestra BioMed Holdings (OBIO) with Overweight Recommendation - MSN

Jan 03, 2025

Jan 02, 2025

Orchestra BioMed shares get shot in the arm on solid clinical trial data - Mugglehead

Jan 02, 2025

US Penny Stocks Spotlight: AC Immune And Two Others To Consider - Simply Wall St

Jan 02, 2025

Orchestra BioMed Up 49% After Barclays Starts Coverage With $16 Target - MarketWatch

Jan 02, 2025

Stock market news: Rain Oncology +371.17%, SuperCom +75.93% among top gainers during mid day trading - Business Upturn

Jan 02, 2025

Orchestra BioMed (NASDAQ:OBIO) Now Covered by Barclays - MarketBeat

Jan 02, 2025

This Kopin Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday - Benzinga

Jan 02, 2025

Orchestra Orchestra BioMed stock rated Overweight on novel medtech model By Investing.com - Investing.com Nigeria

Jan 02, 2025

State Street Corp Has $2.21 Million Stock Holdings in Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO) - Defense World

Jan 02, 2025

Dec 27, 2024

Orchestra Biomed CEO David Hochman buys $18,640 in common stock By Investing.com - Investing.com Australia

Dec 27, 2024

Dec 26, 2024

Orchestra Biomed CEO David Hochman buys $18,640 in common stock - Investing.com India

Dec 26, 2024

Insider Buying: Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO) Insider Purchases 4,000 Shares of Stock - MarketBeat

Dec 26, 2024

Dec 25, 2024

Orchestra BioMed Holdings, Inc.'s (NASDAQ:OBIO) top owners are individual investors with 26% stake, while 22% is held by hedge funds - Yahoo Finance

Dec 25, 2024

Dec 20, 2024

Orchestra BioMed CFO Taylor Lawrence buys $4,830 in company stock - Investing.com

Dec 20, 2024

Dec 19, 2024

Orchestra Biomed CEO David Hochman buys $24,550 in stock By Investing.com - Investing.com Canada

Dec 19, 2024

Orchestra Biomed CEO David Hochman buys $24,550 in stock - Investing.com India

Dec 19, 2024

Insider Buying: Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO) Insider Acquires 5,000 Shares of Stock - MarketBeat

Dec 19, 2024

Dec 18, 2024

Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO) Shares Bought by Charles Schwab Investment Management Inc. - Defense World

Dec 18, 2024

Here's Why We're Watching Orchestra BioMed Holdings' (NASDAQ:OBIO) Cash Burn Situation - Simply Wall St

Dec 18, 2024

Dec 17, 2024

Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO) Stock Position Lowered by The Manufacturers Life Insurance Company - Defense World

Dec 17, 2024

Dec 11, 2024

(OBIO) Pivots Trading Plans and Risk Controls - Stock Traders Daily

Dec 11, 2024

Dec 09, 2024

OBIOOrchestra BioMed Holdings, Inc. Ordinary Shares Latest Stock News & Market Updates - StockTitan

Dec 09, 2024

Orchestra BioMed Announces AVIM Therapy Program Presentations at ICI Meeting - GlobeNewswire

Dec 09, 2024

Orchestra BioMed to Present Breakthrough AVIM Therapy Data for Hypertension Treatment at ICI 2024 - StockTitan

Dec 09, 2024

Dec 08, 2024